GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TMS Co Ltd (TSE:4891) » Definitions » Net Income From Continuing Operations

TMS Co (TSE:4891) Net Income From Continuing Operations : 円-564.31 Mil (TTM As of Nov. 2023)


View and export this data going back to 2022. Start your Free Trial

What is TMS Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. TMS Co's net income from continuing operations for the three months ended in Nov. 2023 was 円-221.69 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Nov. 2023 was 円-564.31 Mil.

TMS Co Net Income From Continuing Operations Historical Data

The historical data trend for TMS Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TMS Co Net Income From Continuing Operations Chart

TMS Co Annual Data
Trend Feb21 Feb22 Feb23
Net Income From Continuing Operations
-721.98 1,079.30 -861.47

TMS Co Quarterly Data
Feb21 Feb22 Aug22 Nov22 Feb23 May23 Aug23 Nov23
Net Income From Continuing Operations Get a 7-Day Free Trial - - -148.86 -193.77 -221.69

TMS Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-564.31 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TMS Co (TSE:4891) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TMS Co Ltd (TSE:4891) » Definitions » Net Income From Continuing Operations
Comparable Companies
TSE:2370 TSE:3750 TSE:4588 TSE:4598 TSE:4888 TSE:7776 TSE:4572 TSE:4896 TSE:4593 TSE:4594 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
1-9 Fuchu-cho, Fuchu-shi, Keio Fuchu 1-chome building 11th floor, Tokyo, JPN, 183-0055
Website
https://www.tms-japan.co.jp
TMS Co Ltd is engaged in the research and development of pharmaceuticals, quasi-drugs, pharmaceutical raw materials, medical equipment and medical consumables.

TMS Co (TSE:4891) Headlines

No Headlines